Search for: "BRISTOL MYERS SQUIBB COMPANY"
Results 321 - 340
of 465
Sorted by Relevance
|
Sort by Date
29 Jul 2013, 2:24 am
Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
15 Oct 2020, 3:06 am
And don’t forget to tune into our October 29th webcast with CII’s Amy Borrus, Doug Chia of Soundboard Governance, Dorothy Flynn of Broadridge, Independent Inspector of Election Carl Hagberg and Bristol-Myers Squibb’s Kate Kelly to hear what you should be doing right now to prepare. [read post]
8 Mar 2012, 3:34 am
Those competitors included AstraZeneca, Merck & Co., Bristol-Myers Squibb Co., GlaxoSmithKline PLC and others that have disclosed investigations for possible FCPA breaches. [read post]
29 Sep 2019, 4:35 pm
In terms of number of new campaigns, Starboard was the most prolific in H1 2019, deploying $1.2 billion in new capital to target GCP Applied Technologies, Cerner, Bristol-Myers Squibb, KAR, eBay, Zayo, Papa Johns, and Dollar Tree (Lazard). [read post]
26 Jun 2017, 3:34 am
And tune in for our October 10 webcast – “E&S Disclosures: The In-House Perspective” – featuring experts from the Coca-Cola Company, Bristol-Myers Squibb, Apple & Clorox. [read post]
17 May 2021, 1:12 pm
“And Trimble is headquartered in California, connecting California to Trimble’s claims, which is a consideration the Court in Ford found relevant in distinguishing its earlier decision in Bristol-Myers. [read post]
15 Jan 2009, 3:35 am
Just to recap then, the High Court of Delhi recently granted an ex parte restraining order in favour of Bristol Myers Squibb restraining the defendants, Hetero Drugs (an Indian generic firm) from manufacturing, selling, distributing, advertising, exporting, offering for sale or in any manner dealing directly or indirectly in any product infringing the plaintiffs product patent covering Dasatinib, a drug used in the treatment of Chronic Myloeid Leukemia. [read post]
25 Apr 2018, 11:50 am
Ct. 746 (2014)—and particularly in light of the Court’s more recent decisions in Bristol-Myers Squibb Co. v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
1 Oct 2007, 1:08 am
Bristol-Myers Squibb to Pay $515M to Settle Probes of Drug Marketing
The Associated Press
Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. [read post]
27 Apr 2009, 9:43 am
Bristol-Myers Squibb Co., 25 No. 3 Andrews Pharmaceutical Litig. [read post]
22 Dec 2011, 5:01 am
[Link] Bristol-Myers Squibb is seeking an IP Counsel with 5+ years of patent attorney experience and a background in molecular biology or biochemistry to work at their New Jersey location. [read post]
2 Jun 2010, 3:15 am
” Bristol-Myers Squibb Co., 326 F.3d at 1241; see Molins PLC, 48 F.3d at 1182 (“We recognize that [the withheld references] were cited eventually to the PTO and that the examiner . . . passed the reexamination application to issue thereafter. [read post]
8 Aug 2014, 5:00 am
In Bristol-Myers Squibb Co. v. [read post]
19 Jun 2014, 8:11 am
TAP Pharmaceuticals (Bristol Myers Squibb Appeal), No. 85 MAP 2011, slip op. [read post]
8 Jan 2013, 9:39 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
5 Apr 2011, 6:01 pm
to join Bristol Myers Squibb and GlaxoSmithKline in their efforts to prevent the illegal production of patented AIDS drugs in Africa? [read post]
24 Mar 2015, 11:54 am
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
3 Feb 2010, 2:00 am
(Docket Report) Sustiva (Efavirenz) – US: Mylan and Matrix fail in bid to dismiss Sustiva case brought by Bristol Myer Squibb (Patent Docs) Temodar (Temozolomide) – US: District Court Delaware: Temador patent unenforceable due to prosecution laches and inequitable conduct: Cancer Research Tech v Barr Labs (Docket Report) (Patent Baristas) (IP Factor) Viread (Tenofovir) – US: Gilead Sciences announces notification of Teva’s ANDA filing for Viread… [read post]
